Jefferies Analyst Upgrades Corbus Pharmaceuticals to Buy Raises Price Target
On March 6, 2024, Jefferies analyst Maury Raycroft made a bold move by upgrading Corbus Pharmaceuticals (NASDAQ: CRBP) from a ...
© 2024 Stocks Today
Tag: CRBP
Corbus Pharmaceuticals Raises Funds for Clinical Development and Faces Market Fluctuations
On February 1, 2024, Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) successfully completed an underwritten public offering, raising approximately $82.2 million ...
Corbus Pharmaceuticals Holdings Unprecedented Surge and Trading Halt
On January 27, 2024, Corbus Pharmaceuticals Holdings witnessed an extraordinary surge in its stock price, causing a temporary halt in ...
Corbus Pharmaceuticals Holdings Inc Surges on Promising Drug Candidate CRB701
On January 27, 2024, Corbus Pharmaceuticals Holdings, Inc. made an exciting revelation about its drug candidate CRB-701, leading to a ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape